Annette Snejbjerg Bartels

Annette Snejbjerg Bartels


  1. 2013
  2. Published

    Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial? / Munro, Alison F.; Bartels, Annette; Balslev, Eva; Twelves, Christopher J.; Cameron, David A; Brünner, Nils; Bartlett, John Ms.

    In: Breast Cancer Research (Online Edition), Vol. 15, No. 2, R31, 2013.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 6090964